Mitsuhiro Takeno Selected Research

Mitsuhiro Takeno Research Topics

Disease

9	Rheumatoid Arthritis 01/2023 - 04/2006
7	Oral Ulcer (Mouth Ulcer) 10/2022 - 11/2019
6	Behcet Syndrome (Behcet's Syndrome) 01/2024 - 12/2003
6	Inflammation (Inflammations) 12/2018 - 04/2006
5	Disease Progression 10/2020 - 02/2003
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 01/2016
3	Arthritis (Polyarthritis) 10/2022 - 01/2022
3	Ulcer 10/2022 - 06/2010
3	Nausea 09/2021 - 11/2019
3	Infections 09/2020 - 07/2011
2	Systemic Scleroderma (Systemic Sclerosis) 10/2022 - 06/2010
2	Pain (Aches) 01/2022 - 09/2021
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 01/2019
2	Neoplasms (Cancer) 01/2022 - 07/2021
2	Headache (Headaches) 09/2021 - 11/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2020 - 02/2013
2	Lung Neoplasms (Lung Cancer) 01/2010 - 02/2003
2	Tuberculosis (Tuberculoses) 05/2009 - 07/2007
1	Dyspnea (Shortness of Breath) 01/2023
1	Pulmonary Sarcoidosis 01/2023
1	Granuloma 01/2023
1	Oral Manifestations 10/2022
1	Skin Ulcer 10/2022
1	Erythema Nodosum 10/2022
1	digital ulcers 10/2022
1	Ischemia 10/2022
1	Gangrene 10/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	Paralysis (Palsy) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2021
1	Necrosis 07/2021
1	Lymphoma (Lymphomas) 01/2021
1	Hypesthesia (Numbness) 01/2021
1	Iridocyclitis 01/2021
1	Dermatomyositis (Dermatopolymyositis) 09/2020
1	Diarrhea 11/2019
1	Myocarditis (Carditis) 01/2019
1	Respiratory Paralysis 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2018
1	Lupus Nephritis 10/2018
1	Communicable Diseases (Infectious Diseases) 07/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2017
1	Autoimmune Diseases (Autoimmune Disease) 07/2017
1	Bacterial Pneumonia 07/2017
1	Thymoma (Thymic Carcinoma) 07/2017
1	Exfoliative Dermatitis (Erythroderma) 07/2017
1	Parotitis (Parotiditis) 01/2016
1	Multifocal fibrosclerosis 01/2016
1	Immunoglobulin G4-Related Disease 01/2016
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2016
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 07/2015
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 07/2015
1	Familial Mediterranean Fever (Periodic Disease) 05/2013
1	Hashimoto's encephalitis 02/2013

Drug/Important Bio-Agent (IBA)

7	apremilastIBA 10/2022 - 11/2019
5	Infliximab (Remicade)FDA Link 06/2023 - 12/2003
5	Heme Oxygenase-1IBA 05/2012 - 04/2006
4	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 09/2020
4	Interleukin-10 (Interleukin 10)IBA 12/2018 - 08/2010
3	Heme (Haem)IBA 10/2018 - 01/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2011 - 12/2003
2	Interleukin-6 (Interleukin 6)IBA 01/2024 - 06/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 10/2020
2	SteroidsIBA 10/2022 - 07/2017
2	AntibodiesIBA 10/2022 - 02/2013
2	Immunosuppressive Agents (Immunosuppressants)IBA 07/2021 - 01/2019
2	Rituximab (Mabthera)FDA Link 01/2021 - 07/2015
2	Biomarkers (Surrogate Marker)IBA 09/2020 - 10/2006
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2015 - 10/2003
2	Tumor Necrosis Factor InhibitorsIBA 07/2011 - 02/2007
2	EnzymesIBA 05/2008 - 04/2006
1	nintedanibIBA 01/2023
1	Anti-Citrullinated Protein AntibodiesIBA 01/2023
1	Vasodilator Agents (Vasodilators)IBA 10/2022
1	AutoantibodiesIBA 10/2022
1	Contrast MediaIBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	Colchicine FDA LinkGeneric 07/2021
1	HLA-A*26 antigenIBA 01/2021
1	Phosphodiesterase 4 InhibitorsIBA 03/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	InterferonsIBA 11/2018
1	Interferon Type IIBA 10/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2017
1	Immunoglobulins (Immunoglobulin)IBA 07/2017
1	HLA-B51 AntigenIBA 10/2016
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	CPNBDIBA 02/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Unithiol (DMPS)IBA 09/2013
1	Toll-Like Receptor 4IBA 05/2013

Therapy/Procedure

9	Therapeutics 01/2023 - 02/2003
1	Activities of Daily Living (ADL) 01/2022
1	Remission Induction 01/2021
1	Thymectomy 07/2017
1	Drug Therapy (Chemotherapy) 07/2017
1	Immunotherapy 02/2013